Trifluridine
Pricing Report NDC 59762-0040-1

Latest NADAC: $15.82978 per ML · Effective Jan 17, 2018 · Est. package price $118.72 (7.5 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Trifluridine (NDC 59762-0040-1) is $15.82978 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 17, 2018.

As a provided by Greenstone Llc, this medication is distributed in a 1 BOTTLE, DROPPER in 1 CARTON / 7.5 mL in 1 BOTTLE, DROPPER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$15.82978
Per ML

Effective Date
Jan 17, 2018
Billable Units
7.5 ML
Estimated Package Price
$118.72
Data Status
As of Feb 21, 2018
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, DROPPER in 1 CARTON / 7.5 mL in 1 BOTTLE, DROPPER
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $14.82400 to $18.76498 per ML. Over this 4 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$14.8240 - $18.7650
Market Volatility
26.59% Variance
Latest Trend
6.78%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jan 17, 2018 $15.82978 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 17, 2018 $15.82978 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Nov 22, 2017 $14.82400 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 22, 2017 $14.82400 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Sep 20, 2017 $16.54054 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 20, 2017 $16.54054 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Jul 19, 2017 $15.23367 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 19, 2017 $15.23367 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic
Jun 21, 2017 $16.90480 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2017 $16.45453 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 19, 2017 $16.20294 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 22, 2017 $15.60838 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026